Get In Touch

Listeria monocytogenes, is a gram positive, facultative anaerobic, intracellular, ubiquitous bacterium which causes infections known as listeriosis. This foodborne pathogen causes serious infections in pregnant women and their babies, elderly people, and immune-compromised people. Pregnant women infected with listeria monocytogenes can pass the infection to the fetus. Listeria infection in pregnant women can cause stillbirths, miscarriages, and preterm labor. It is estimated that nearly 1,600 people are infected by listeriosis and around 260 people die due to infections caused by listeria monocytogenes every year. The infection primarily occurs due to the ingestion of food contaminated with the bacterium. The disease is usually diagnosed by performing microbiological examination of body fluids such as placental fluid, blood, and spinal fluid. Listeriosis leads to a variety of symptoms which include muscle ache, fever, and flu-like symptoms in pregnant women. Symptoms in people other than pregnant women include stiff neck, head ache, loss of balance, confusion, and convulsions, in addition to muscle ache and fever. Other complications of listeriosis include sepsis, meningitis, and meningoencephalitis. People can also experience focal infections including infections of site inside in abdomen and chest, arthritis, osteomyelitis, and septic prosthetic graft infections, or of the skin and eye.

Increase in prevalence of foodborne infections is driving the global Listeria monocytogenes treatment market. Increase in consumption of frozen food such as vegetables, meat, and dairy products has increased the frequency of listeriosis. The Centers of Disease Control and Prevention states that listeria is the third leading cause of death from foodborne illnesses. Additionally, increasing awareness about the disease and its treatment method is propelling the global listeria monocytogenes treatment market.

The global Listeria monocytogenes treatment market can be segmented based on patient type, type of infection, type of antibiotic, and geography. In terms of type of infection, the global listeria monocytogenes treatment market can be segregated into meningitis, gastroenteritis, endocarditis, bacteremia, and brain abscess. Based on type of infection, the Listeria monocytogenes market can be divided into pregnant women, neonates, geriatric population of 65 years of age and above, and others. Pregnant women are more prone to contracting listeriosis due to the ingestion of contaminated food. Additionally, immune-compromised people are susceptible to the Listeria monocytogenes infection. Based on type of antibiotic, the global listeria monocytogenes treatment market is divided into ampicillin, gentamicin, vancomycin, and others. Currently, no specific vaccine is available in the market for listeriosis.

In terms of geography, the global listeria monocytogenes treatment market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Globally, North America, Africa, and Southeast Asia are facing major problems due to the lack of treatments available for listeria monocytogenes infections. High cost of the drugs restricts Listeria monocytogenes treatment in many endemic regions. However, increasing awareness about the disease and rise in incidence rate of the disease around the globe are projected to drive the market. Moreover, the unmet medical need is estimated to present an opportunity for research and development programs to invest in the global Listeria monocytogenes treatment market. Currently, no vaccination is available for the treatment of this disease, and the focus relies on chemotherapy and prevention and control measures of Listeria monocytogenes infections.

Key players operating in the global listeria monocytogenes treatment market include Eli Lilly and Company, Pfizer, Inc., Abbott, GlaxoSmithKline plc, Janssen Pharmaceuticals, Sanofi, Bayer AG, Novartis AG, Astellas Pharma, Inc. and Bristol Myers Squibb Company.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Listeria Monocytogenes Treatment Market

Pre Book